530 related articles for article (PubMed ID: 31030566)
21. An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism.
Nieschlag E; Bouloux PG; Stegmann BJ; Shankar RR; Guan Y; Tzontcheva A; McCrary Sisk C; Behre HM
Reprod Biol Endocrinol; 2017 Mar; 15(1):17. PubMed ID: 28270212
[TBL] [Abstract][Full Text] [Related]
22. Testosterone undecanoate supplementation together with human chorionic gonadotropin does not impair spermatogenesis in males with isolated hypogonadotropic hypogonadism: a retrospective study.
Chen YW; Niu YH; Xu H; Wang DQ; Jiang HY; Pokhrel G; Wang T; Wang SG; Liu JH
Asian J Androl; 2019; 21(4):413-418. PubMed ID: 30604694
[TBL] [Abstract][Full Text] [Related]
23. Hormonal therapy (hCG and rhFSH) for infertile men with adult-onset idiopathic hypogonadotropic hypogonadism.
Kobori Y; Suzuki K; Iwahata T; Shin T; Sato R; Nishio K; Yagi H; Arai G; Soh S; Okada H
Syst Biol Reprod Med; 2015 Apr; 61(2):110-2. PubMed ID: 25518839
[TBL] [Abstract][Full Text] [Related]
24. Predictors of pilosebaceous unit responsiveness to testosterone therapy in patients with hypogonadotrophic hypogonadism.
Dhiman P; Bhansali A; Prasad R; Dutta P; Walia R; Ravikiran M
Andrologia; 2011 Dec; 43(6):422-7. PubMed ID: 21486418
[TBL] [Abstract][Full Text] [Related]
25. CAG repeat testing of androgen receptor polymorphism: is this necessary for the best clinical management of hypogonadism?
Francomano D; Greco EA; Lenzi A; Aversa A
J Sex Med; 2013 Oct; 10(10):2373-81. PubMed ID: 23844628
[TBL] [Abstract][Full Text] [Related]
26. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens.
Ley SB; Leonard JM
J Clin Endocrinol Metab; 1985 Oct; 61(4):746-52. PubMed ID: 3928676
[TBL] [Abstract][Full Text] [Related]
27. Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?
Giagulli VA; Carbone MD; De Pergola G; Guastamacchia E; Resta F; Licchelli B; Sabbà C; Triggiani V
J Assist Reprod Genet; 2014 Jun; 31(6):689-97. PubMed ID: 24691874
[TBL] [Abstract][Full Text] [Related]
28. Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism--diagnostic and therapeutic aspects.
Delemarre-van de Waal HA
Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U89-94. PubMed ID: 15554892
[TBL] [Abstract][Full Text] [Related]
29. Hormonal replacement therapy with HCG and HU-FSH in thalassaemic patients affected by hypogonadotropic hypogonadism.
Cisternino M; Manzoni SM; Coslovich E; Autelli M
J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():885-90. PubMed ID: 10091162
[TBL] [Abstract][Full Text] [Related]
30. No association of androgen receptor GGN repeat length polymorphism with infertility in Indian men.
Rajender S; Rajani V; Gupta NJ; Chakravarty B; Singh L; Thangaraj K
J Androl; 2006; 27(6):785-9. PubMed ID: 16809273
[TBL] [Abstract][Full Text] [Related]
31. Influence of androgen receptor CAG polymorphism on sexual function recovery after testosterone therapy in late-onset hypogonadism.
Tirabassi G; Corona G; Biagioli A; Buldreghini E; delli Muti N; Maggi M; Balercia G
J Sex Med; 2015 Feb; 12(2):381-8. PubMed ID: 25443437
[TBL] [Abstract][Full Text] [Related]
32. Induction of puberty with human chorionic gonadotropin and follicle-stimulating hormone in adolescent males with hypogonadotropic hypogonadism.
Barrio R; de Luis D; Alonso M; Lamas A; Moreno JC
Fertil Steril; 1999 Feb; 71(2):244-8. PubMed ID: 9988392
[TBL] [Abstract][Full Text] [Related]
33. [Dysfunction of hypothalamic-pituitary-testicular axis in patients with adrenal hypoplasia congenita due to DAX-1 gene mutation].
Zheng JJ; Wu XY; Nie M; Liu ZX; Wang X; Huang BK; Fu Y; Lu L; Duan L; Mao JF
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(15):1183-7. PubMed ID: 27117364
[TBL] [Abstract][Full Text] [Related]
34. Androgen receptor gene haplotype is associated with male infertility.
Saare M; Belousova A; Punab M; Peters M; Haller K; Ausmees K; Poolamets O; Karro H; Metspalu A; Salumets A
Int J Androl; 2008 Aug; 31(4):395-402. PubMed ID: 17651405
[TBL] [Abstract][Full Text] [Related]
35. Pituitary and gonadal function in the infant son of a patient with hypogonadotropic hypogonadism.
Cassorla FG; Pescovitz O; Loriaux DL; Sherins RJ
J Endocrinol Invest; 1985 Feb; 8(1):71-2. PubMed ID: 3921598
[TBL] [Abstract][Full Text] [Related]
36. Feedback inhibition of gonadotropins by testosterone in men with hypogonadotropic hypogonadism: comparison to the intact pituitary-testicular axis in primary hypogonadism.
Shimon I; Lubina A; Gorfine M; Ilany J
J Androl; 2006; 27(3):358-64. PubMed ID: 16474013
[TBL] [Abstract][Full Text] [Related]
37. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism.
Schaison G; Young J; Pholsena M; Nahoul K; Couzinet B
J Clin Endocrinol Metab; 1993 Dec; 77(6):1545-9. PubMed ID: 8263139
[TBL] [Abstract][Full Text] [Related]
38. Optimal treatment for spermatogenesis in male patients with hypogonadotropic hypogonadism.
Lin J; Mao J; Wang X; Ma W; Hao M; Wu X
Medicine (Baltimore); 2019 Aug; 98(31):e16616. PubMed ID: 31374027
[TBL] [Abstract][Full Text] [Related]
39. Androgen receptor gene CAG and GGN repeat lengths as predictors of recovery of spermatogenesis following testicular germ cell cancer treatment.
Bogefors K; Giwercman YL; Eberhard J; Stahl O; Cavallin-Stahl E; Cohn-Cedermark G; Arver S; Giwercman A
Asian J Androl; 2017; 19(5):538-542. PubMed ID: 27873769
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
